Arun J Sanyal Selected Research

Peritonitis

1/2010	Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
7/2009	Ascites: diagnosis and management.
5/2009	Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
12/2005	Hepatorenal syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arun J Sanyal Research Topics

Disease

160	Fibrosis (Cirrhosis) 06/2024 - 01/2003
159	Non-alcoholic Fatty Liver Disease 04/2024 - 06/2003
54	Inflammation (Inflammations) 12/2023 - 06/2005
41	Liver Diseases (Liver Disease) 03/2024 - 05/2004
33	Alcoholic Fatty Liver 11/2023 - 01/2009
30	Fatty Liver 03/2024 - 05/2003
28	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 09/2013
27	Insulin Resistance 03/2024 - 10/2002
23	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 10/2004
16	Obesity 05/2024 - 10/2006
14	Ascites 06/2024 - 03/2003
14	Infections 02/2024 - 05/2003
14	End Stage Liver Disease 12/2021 - 10/2004
12	Hepatic Encephalopathy 01/2024 - 09/2005
10	Dyslipidemias (Dyslipidemia) 03/2024 - 08/2010
10	Hemorrhage 01/2024 - 12/2003
10	Hepatorenal Syndrome 01/2024 - 05/2008
10	Alcoholic Hepatitis 12/2023 - 12/2005
10	Disease Progression 07/2023 - 01/2015
9	Type 2 Diabetes Mellitus (MODY) 05/2024 - 09/2013
8	Portal Hypertension 01/2023 - 11/2005
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2005
8	Chronic Hepatitis C 10/2014 - 05/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 12/2013
7	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 08/2009
7	Neoplasms (Cancer) 01/2023 - 02/2008
6	Nausea 01/2024 - 09/2008
6	Liver Neoplasms (Liver Cancer) 11/2022 - 08/2010
6	Weight Loss (Weight Reduction) 11/2022 - 09/2013
6	Hepatitis C 03/2018 - 07/2004
5	Body Weight (Weight, Body) 05/2024 - 03/2016
5	Hypertension (High Blood Pressure) 01/2023 - 01/2019
5	Pruritus (Itching) 01/2023 - 03/2015
4	Varicose Veins (Varicose Vein) 05/2024 - 12/2006
4	Hepatitis 02/2024 - 01/2013
4	Diarrhea 01/2024 - 01/2021
4	Weight Gain 05/2023 - 08/2017
4	Cognitive Dysfunction 01/2023 - 01/2013
4	Hepatitis B 10/2022 - 04/2007

Drug/Important Bio-Agent (IBA)

43	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2006
32	LipidsIBA 03/2024 - 10/2002
21	Alanine Transaminase (SGPT)IBA 10/2023 - 01/2003
18	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024 - 10/2009
17	nasIBA 01/2023 - 06/2005
16	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 10/2002
14	obeticholic acidIBA 11/2023 - 09/2013
14	Bile Acids and Salts (Bile Acids)IBA 12/2022 - 09/2013
13	EnzymesIBA 01/2022 - 09/2008
11	Proteins (Proteins, Gene)FDA Link 04/2023 - 10/2006
11	Vitamin E FDA LinkGeneric 11/2019 - 12/2004
10	Fatty Acids (Saturated Fatty Acids)IBA 03/2024 - 06/2008
10	Lipoproteins (Lipoprotein)IBA 11/2023 - 12/2013
10	Antiviral Agents (Antivirals)IBA 11/2023 - 06/2005
10	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2008
10	Insulin (Novolin)FDA Link 01/2021 - 10/2002
10	Pioglitazone (Actos)FDA Link 01/2020 - 12/2004
9	CollagenIBA 11/2022 - 10/2006
8	TerlipressinIBA 12/2023 - 12/2003
8	AlbuminsIBA 11/2023 - 12/2005
8	CytokinesIBA 01/2023 - 01/2005
8	Triglycerides (Triacylglycerol)IBA 12/2022 - 05/2012
8	Ribavirin (Virazole)FDA LinkGeneric 10/2014 - 05/2004
8	InterferonsIBA 07/2014 - 05/2004
7	Rifaximin (L 105)FDA Link 06/2024 - 02/2011
7	CholesterolIBA 01/2022 - 05/2012
6	BilirubinIBA 11/2023 - 05/2006
6	Hormones (Hormone)IBA 09/2023 - 05/2003
6	LDL CholesterolIBA 12/2022 - 05/2012
6	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2003
6	SodiumIBA 01/2021 - 03/2003
5	semaglutideIBA 03/2024 - 01/2021
5	PegbelferminIBA 04/2023 - 01/2021
5	oxidized low density lipoproteinIBA 01/2023 - 12/2013
5	DiamondIBA 01/2023 - 01/2016
5	CreatinineIBA 01/2021 - 08/2011
5	LigandsIBA 01/2019 - 01/2013
4	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2024 - 03/2016
4	Peptides (Polypeptides)IBA 05/2024 - 01/2015
4	resmetiromIBA 03/2024 - 01/2022
4	aldaferminIBA 09/2023 - 01/2021
4	Protons (Proton)IBA 04/2023 - 10/2020
4	Indicators and Reagents (Reagents)IBA 01/2023 - 08/2010
4	SugarsIBA 01/2023 - 12/2017
4	saroglitazarIBA 01/2023 - 01/2020
4	simtuzumabIBA 01/2023 - 10/2018
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023 - 12/2017
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 05/2012
4	LDL Lipoproteins (beta Lipoproteins)IBA 10/2021 - 05/2015
4	AnticoagulantsIBA 10/2021 - 10/2006
4	Transaminases (Aminotransferases)IBA 11/2020 - 09/2010
4	Fatty Acid Synthases (Fatty Acid Synthase)IBA 02/2020 - 01/2015
4	CaspasesIBA 01/2020 - 02/2012

Therapy/Procedure

66	Therapeutics 03/2024 - 03/2003
38	Liver Transplantation 05/2024 - 06/2003
9	Drug Therapy (Chemotherapy) 12/2021 - 11/2008
7	Transplantation 01/2023 - 10/2004
6	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2016 - 03/2003
6	Transjugular Intrahepatic Portasystemic Shunt 09/2015 - 03/2003
5	Bariatric Surgery 10/2023 - 05/2014
4	Aftercare (After-Treatment) 11/2023 - 03/2018